Claim being checked · Version 1 · Reviewed
“LL-37 is a 37-amino-acid human peptide.”
Written and source-checked by Anthony Treviso, founder of The Peptide Field.
No dosing advice. This guide explains research. It was not independently medically reviewed, and it does not diagnose, prescribe, or recommend treatment.
Supported with scope. The reviewed evidence supports this exact statement only in the situation described below.
Answer scope
This verdict checks the exact claim in the heading. It is not a universal grade for LL-37.
01 · Answer
Supported with scope
FDA's detailed chemical record lists ropocamptide as a peptide with 37 amino acids. This record does not show product quality or human benefit.
- What kind of evidence this is
- Regulatory or product record. This answer uses an official regulator record or a specific product label.
- What this answer covers
- FDA identity records for LL-37 and ropocamptide; this does not establish the identity or quality of an online product. This answer covers only the named molecule and finished product. It also covers the product form and how people used it. The study limits include who took part, what was used for comparison, what changed, and how long the study lasted.
- Question type
- Mechanism and biomarkers. How a substance changed the body or a lab measurement. This may not show a health benefit.
02 · Sources
Read the sources behind this answer
01FDA Global Substance Registration System record for ropocamptide (LL-37)U.S. Food and Drug Administration · Reference · 2026
Supports the scoped claim02Human cathelicidin precursor processing to LL-37PubMed · Reference · 2001
Supports the scoped claim
Supports the scoped claim02Human cathelicidin precursor processing to LL-37PubMed · Reference · 2001
Supports the scoped claim
- Editorial review
- Internal editorial review recorded
- Source review
- Anthony Treviso · Founder and responsible editor
- Medical review status
- Not independently medically reviewed. Editorial source review does not replace medical review.